Testa et al., 2021)
In some embodiments, the formulations described herein have a deliverable osmolarity of about 150 mOsm/L to about 500 mOsm/L, about 250 mOsm/L to about 500 mOsm/L, about 250 mOsm/L to about 350 mOsm/L, about 280 mOsm/L to about 370 mOsm/L or about 250 mOsm/L to about 320 mOsm/L
The peptide is currently approved in over 30 countries for viral hepatitis and other immunosuppressive conditions
Recalls & Warnings May 01, 2023 TruVision Recalls Products Due to Presence of Potentially Dangerous Ingredients On April 27, 2023, TruVision Health issued a recall of various dietary supplement products because they contain hordenine and/or octodrine/DMHA, compounds that the FDA considers to be possibly unsafe and which are not permitted to be sold as dietary supplements
This is why cagrilintide, which operates through completely different receptors, makes a more logical combination partner than additional GLP-1 agonists